{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:50:46Z","timestamp":1783633846842,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00392-025-02741-1","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:58:47Z","timestamp":1756108727000},"page":"1400-1413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and efficacy of early use of mineralocorticoid receptor antagonists in cardiogenic shock: a propensity score-matched analysis"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8952-6283","authenticated-orcid":false,"given":"Miloud","family":"Cherbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Puymirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyer","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bonnefoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"2741_CR1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 42:3599\u20133726","journal-title":"Eur Heart J."},{"key":"2741_CR2","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/ehf2.15046","volume":"12","author":"M Cherbi","year":"2025","unstructured":"Cherbi M, Roubille F, Gerbaud E, Bonnefoy E, Lamblin N, Bonello L, Levy B, Lim P, Merdji H, Elbaz M, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Combaret N, Lattuca B, Leurent G, Puymirat E, Delmas C (2025) Clinical profile, short and long-term outcomes of non-ischaemic cardiogenic shock: a FRENSHOCK sub-analysis. ESC Heart Fail 12:2335\u20132346","journal-title":"ESC Heart Fail"},{"key":"2741_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/ejhf.585","volume":"18","author":"N Aissaoui","year":"2016","unstructured":"Aissaoui N, Puymirat E, Juilliere Y, Jourdain P, Blanchard D, Schiele F, Gu\u00e9ret P, Popovic B, Ferrieres J, Simon T, Danchin N (2016) Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme. Eur J Heart Fail 18:1144\u20131152","journal-title":"Eur J Heart Fail"},{"key":"2741_CR4","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s00134-024-07618-x","volume":"50","author":"C Jung","year":"2024","unstructured":"Jung C, Bruno RR, Jumean M, Price S, Krychtiuk KA, Ramanathan K, Dankiewicz J, French J, Delmas C, Mendoza AA, Thiele H, Soussi S (2024) Management of cardiogenic shock: state-of-the-art. Intensive Care Med 50:1814\u20131829","journal-title":"Intensive Care Med"},{"key":"2741_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.healun.2023.09.014","volume":"43","author":"MK Kanwar","year":"2024","unstructured":"Kanwar MK, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, Ensminger S, Hernandez-Montfort J, Sinha SS, Vorovich E, Proudfoot A, Lim HS, Blumer V, Jennings DL, Reshad Garan A, Renedo MF, Hanff TC, Baran DA, Consensus Conference participants (2024) Heart failure related cardiogenic shock: an ISHLT consensus conference content summary. J Heart Lung Transplant 43:189\u2013203","journal-title":"J Heart Lung Transplant"},{"key":"2741_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","volume":"25","author":"JP Ferreira","year":"2014","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H (2014) Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. Eur J Intern Med 25:67\u201372","journal-title":"Eur J Intern Med"},{"issue":"415","key":"2741_CR7","doi-asserted-by":"publisher","first-page":"132477","DOI":"10.1016\/j.ijcard.2024.132477","volume":"15","author":"M Kobayashi","year":"2024","unstructured":"Kobayashi M, Yamashina A, Satomi K, Tezuka A, Ito S, Asakura M, Kitakaze M, Ferreira JP (2024) Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure. Int J Cardiol 15(415):132477","journal-title":"Int J Cardiol"},{"key":"2741_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.acvd.2019.02.001","volume":"112","author":"C Delmas","year":"2019","unstructured":"Delmas C, Puymirat E, Leurent G, Elbaz M, Manzo-Silberman S, Bonello L, Gerbaud E, Bataille V, Levy B, Lamblin N, Bonnefoy E, Henry P, Roubille F, FRENSHOCK investigators (2019) Design and preliminary results of FRENSHOCK 2016: a prospective nationwide multicentre registry on cardiogenic shock. Arch Cardiovasc Dis 112:343\u2013353","journal-title":"Arch Cardiovasc Dis"},{"issue":"10","key":"2741_CR9","doi-asserted-by":"publisher","first-page":"1167738","DOI":"10.3389\/fcvm.2023.1167738","volume":"5","author":"M Cherbi","year":"2023","unstructured":"Cherbi M, Bonnefoy E, Lamblin N, Gerbaud E, Bonello L, Roubille F, Levy B, Champion S, Lim P, Schneider F, Elbaz M, Khachab H, Bourenne J, Seronde MF, Schurtz G, Harbaoui B, Vanzetto G, Combaret N, Labbe V, Marchandot B, Lattuca B, Biendel-Picquet C, Leurent G, Puymirat E, Maury P, Delmas C (2023) One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry. Front Cardiovasc Med 5(10):1167738","journal-title":"Front Cardiovasc Med"},{"issue":"94","key":"2741_CR10","first-page":"29","volume":"1","author":"DA Baran","year":"2019","unstructured":"Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O\u2019Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS (2019) SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 1(94):29\u201337","journal-title":"Catheter Cardiovasc Interv"},{"key":"2741_CR11","doi-asserted-by":"publisher","first-page":"e007099","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","volume":"13","author":"KL Thayer","year":"2020","unstructured":"Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez-Montfort J, Mahr C, Morine KJ, Newman S, Jorde L, Haywood JL, Harwani NM, Esposito ML, Davila CD, Wencker D, Sinha SS, Vorovich E, Abraham J, O\u2019Neill W, Udelson J, Burkhoff D, Kapur NK (2020) Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail 13:e007099","journal-title":"Circ Heart Fail"},{"key":"2741_CR12","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","volume":"2","author":"J Butler","year":"2017","unstructured":"Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, Hernandez AF, Braunwald E, National heart lung and blood institute heart failure clinical research network (2017) Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial. JAMA Cardiol 2:950\u2013958","journal-title":"JAMA Cardiol"},{"key":"2741_CR13","first-page":"108","volume":"8","author":"M Asakura","year":"2022","unstructured":"Asakura M, Ito S, Yamada T, Saito Y, Kimura K, Yamashina A, Hirayama A, Kobayashi Y, Hanatani A, Tsujimoto M, Yasuda S, Abe Y, Higashino Y, Tamaki Y, Sugino H, Niinuma H, Okuhara Y, Koitabashi T, Momomura SI, Asai K, Nomura A, Kawai H, Satoh Y, Yoshikawa T, Hirata KI, Yokoi Y, Tanaka J, Shibata Y, Maejima Y, Tamaki S, Kawata H, Iwahashi N, Kobayashi M, Higuchi Y, Kada A, Yamamoto H, Kitakaze M (2022) Efficacy and safety of early initiation of eplerenone treatment in patients with acute heart failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J 8:108\u2013117","journal-title":"Eur Heart J"},{"key":"2741_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321","journal-title":"N Engl J Med"},{"key":"2741_CR15","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","volume":"10","author":"EW Steyerberg","year":"2013","unstructured":"Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG, PROGRESS Group (2013) Prognosis research strategy (PROGRESS) 3: prognostic model research. PLoS Med 10:e1001381","journal-title":"PLoS Med"},{"key":"2741_CR16","doi-asserted-by":"publisher","first-page":"e011629","DOI":"10.1161\/CIRCHEARTFAILURE.124.011629","volume":"17","author":"JP Ferreira","year":"2024","unstructured":"Ferreira JP, Pitt B, Zannad F (2024) Mineralocorticoid receptor antagonists in heart failure: an update. Circ Heart Fail 17:e011629","journal-title":"Circ Heart Fail"},{"key":"2741_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","volume":"101","author":"CA Farquharson","year":"2000","unstructured":"Farquharson CA, Struthers AD (2000) Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure. Circulation 101:594\u2013597","journal-title":"Circulation"},{"key":"2741_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","volume":"39","author":"J Bauersachs","year":"2002","unstructured":"Bauersachs J, Heck M, Fraccarollo D, Hildemann SK, Ertl G, Wehling M, Christ M (2002) Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. J Am Coll Cardiol 39:351\u2013358","journal-title":"J Am Coll Cardiol"},{"key":"2741_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709\u201317","journal-title":"N Engl J Med"},{"key":"2741_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, EMPHASIS-HF study group (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 364:11\u201321","journal-title":"N Engl J Med."},{"key":"2741_CR21","doi-asserted-by":"publisher","unstructured":"Jolly SS, d\u2019Entremont MA, Pitt B, Lee SF, Mian R, Tyrwhitt J, Kedev S, Montalescot G, Cornel JH, Stankovi\u0107 G, Moreno R, Storey RF, Henry TD, Mehta SR, Bossard M, Kala P, Bhindi R, Zafirovska B, Devereaux PJ, Eikelboom J, Cairns JA, Natarajan MK, Schwalm JD, Sharma SK, Tarhuni W, Conen D, Tawadros S, Lavi S, Asani V, Topic D, Cantor WJ, Bertrand OF, Pourdjabbar A, Yusuf S; CLEAR investigators. Routine spironolactone in acute myocardial infarction. N Engl J Med. 2024 Nov 17. https:\/\/doi.org\/10.1056\/NEJMoa2405923. Epub ahead of print.","DOI":"10.1056\/NEJMoa2405923"},{"key":"2741_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/j.1552-4604.1989.tb03339.x","volume":"29","author":"P Gardiner","year":"1989","unstructured":"Gardiner P, Schrode K, Quinlan D, Martin BK, Boreham DR, Rogers MS, Stubbs K, Smith M, Karim A (1989) Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites. J Clin Pharmacol 29:342\u2013347","journal-title":"J Clin Pharmacol"},{"key":"2741_CR23","doi-asserted-by":"publisher","first-page":"e009295","DOI":"10.1161\/CIRCHEARTFAILURE.121.009295","volume":"15","author":"W Bedrouni","year":"2022","unstructured":"Bedrouni W, Sharma A, Pitt B, Lam CSP, Ni J, Ferreira JP, McMurray J, Giannetti N, Girerd N, Rossignol P, Solomon SD, Claggett B, Pocock S, Huynh T, Zannad F (2022) Timing of statistical benefit of mineralocorticoid receptor antagonists among patients with heart failure and post-myocardial infarction. Circ Heart Fail 15:e009295","journal-title":"Circ Heart Fail"},{"key":"2741_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","volume":"25","author":"JP Ferreira","year":"2014","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H (2014) Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. Eur J Intern Med 25:67\u201372","journal-title":"Eur J Intern Med"},{"key":"2741_CR25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13613-015-0094-4","volume":"5","author":"B Levy","year":"2015","unstructured":"Levy B, Bastien O, Karim B, Cariou A, Chouihed T, Combes A, Mebazaa A, Megarbane B, Plaisance P, Ouattara A, Spaulding C, Teboul JL, Vanhuyse F, Boulain T, Kuteifan K (2015) Experts\u2019 recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care 5:52","journal-title":"Ann Intensive Care"},{"key":"2741_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","volume":"25","author":"JP Ferreira","year":"2014","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H (2014) Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. Eur J Intern Med 25:67\u201372","journal-title":"Eur J Intern Med"},{"key":"2741_CR27","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 145:e895\u2013e1032","journal-title":"Circulation"},{"issue":"19","key":"2741_CR28","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","volume":"73","author":"SJ Greene","year":"2019","unstructured":"Greene SJ, Fonarow GC, DeVore AD, Sharma PP, Vaduganathan M, Albert NM, Duffy CI, Hill CL, McCague K, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Butler J (2019) Titration of medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol 73(19):2365\u20132383","journal-title":"J Am Coll Cardiol"},{"key":"2741_CR29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/ejhf.3295","volume":"26","author":"G Savarese","year":"2024","unstructured":"Savarese G, Lindberg F, Cannata A, Chioncel O, Stolfo D, Musella F, Tomasoni D, Abdelhamid M, Banerjee D, Bayes-Genis A, Berthelot E, Braunschweig F, Coats AJS, Girerd N, Jankowska EA, Hill L, Lainscak M, Lopatin Y, Lund LH, Maggioni AP, Moura B, Rakisheva A, Ray R, Seferovic PM, Skouri H, Vitale C, Volterrani M, Metra M, Rosano GMC (2024) How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC. Eur J Heart Fail 26:1278\u20131297","journal-title":"Eur J Heart Fail"},{"key":"2741_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.01.1239","author":"T Martyn","year":"2020","unstructured":"Martyn T, Faulkenberg KD, Albert CL, Il\u2019Giovine ZJ, Montgomery RA, Randhawa VK, Yaranov DM, Menon V, Estep JD, Tang W, Starling RC (2020) Beneficial acute hemodynamic effects of sacubitril-valsartan in patients with low-cardiac output including significant improvement in PAPi. J Heart Lung Transplant. https:\/\/doi.org\/10.1016\/j.healun.2020.01.1239","journal-title":"J Heart Lung Transplant"},{"key":"2741_CR31","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","volume":"391","author":"SD Solomon","year":"2024","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esper\u00f3n G, Mareev V, Martinez FA, Melenovsk\u00fd V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P, FINEARTS-HF Committees and Investigators (2024) Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 391:1475\u20131485","journal-title":"N Engl J Med."}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02741-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02741-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02741-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T11:34:12Z","timestamp":1758713652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02741-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2741"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02741-1","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}